According to a new study of heart attack patients treated with percutaneous coronary intervention, free access to platelet function testing had only a modest impact on anti-clotting drug selection and dosing. Findings of the TRANSLATE-POPS trial were presented today at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation, TCT is the world's premier educational meeting specializing in interventional cardiovascula...
Fuente : http://www.eurekalert.org/pub_releases/2013-10/crf...
Fuente : http://www.eurekalert.org/pub_releases/2013-10/crf...